Trial Information

Summary: Leukemia - Acute Lymphocytic (ALL)

Callisto Pharmaceuticals, Inc. is currently recruiting subjects with acute lymphocytic leukemia (ALL, cancer of the bone marrow) to participate in an experimental study.

Study drug will be made available to you at no cost.

To qualify, you must:

  • Be 15 years of age or older
  • Be diagnosed with refractory or relapsed ALL
  • Have had no chemotherapy, radiation, or major surgery within 2 weeks of the start of the study
  • Have not participated in another clinical study within 4 weeks of the start of the study
  • Have adequate liver and kidney function

You will not qualify if you:

  • Are pregnant or breastfeeding
  • Are currently on therapy that is or may be active against ALL
  • Have uncontrolled high blood pressure or heart disease

Contact:

Samir Parekh, MD
Biomedical Research Alliance of New York
Montefiore Medical Center
111 East 210th Street
Bronx, NY 10467
Telephone: 718-405-8536
Email:

Profile Page: Biomedical Research Alliance of New York, Bronx, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:22 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA